Congratulations to Dr. Ellis and the Team at Vanderbilt University Medical Center for successfully enrolling over 50 patients into the CONFORM Clinical Trial. His dedication to research and innovation continues to shape the future of cardiology, offering promising solutions for AF-related stroke prevention. Christopher R. Ellis, MD, FACC, FHRS, is a Professor of Cardiovascular Medicine at Vanderbilt University Medical Center. He specializes in Atrial Fibrillation (AF) and stroke risk reduction strategies. He completed his medical training and fellowship at Vanderbilt, focusing on Left Atrial Appendage Closure (LAAC) and cardiac rhythm devices. Dr. Ellis has led groundbreaking research in LAAC and device management, contributing significantly to cardiovascular care. To learn more about the CONFORM Trial, visit the link. https://lnkd.in/e-3W_bZy #Cardiology #LAAO #conformalmedical #claas #Afib #CardioTech #ConformalMedical #interventionalcardiology #electrophysiology CAUTION: Investigational Device The CLAAS System is limited by Federal (or United States) law to investigational use.
Well done Chris!
Prof of Medicine/Dartmouth Chair, 3D Symposium Co-Founder Conformal Medical
3moBravo Chris!!!!!!!